BIOAVAILABILITY OF ORAL AND INTRAMUSCULAR PHENOBARBITAL

被引:41
作者
VISWANATHAN, CT [1 ]
BOOKER, HE [1 ]
WELLING, PG [1 ]
机构
[1] UNIV WISCONSIN,NEUROL & REHABIL HOSP,MADISON,WI 53706
关键词
D O I
10.1002/j.1552-4604.1978.tb02428.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:100 / 105
页数:6
相关论文
共 17 条
[1]   INTRAMUSCULAR ADMINISTRATION OF PHENYTOIN [J].
DAM, M ;
OLESEN, V .
NEUROLOGY, 1966, 16 (03) :288-&
[2]   STUDIES FOLLOWING INTRAMUSCULAR TRITIATED DIGOXIN IN HUMAN SUBJECTS [J].
DOHERTY, JE ;
PERKINS, WH .
AMERICAN JOURNAL OF CARDIOLOGY, 1965, 15 (02) :170-&
[3]  
GAMBLE JAS, 1973, BRIT J ANAESTH, V45, P926
[4]  
GOODMAN SL, 1975, PHARMACOLOGICAL BASI, P110
[5]   SLOW ABSORPTION OF INTRAMUSCULAR CHLORDIAZEPOXIDE [J].
GREENBLATT, DJ ;
SHADER, RI ;
KOCHWESE.J .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (21) :1116-1118
[6]   EVALUATION OF DIGOXIN BIOAVAILABILITY IN SINGLE-DOSE STUDIES [J].
GREENBLATT, DJ ;
DUHME, DW ;
KOCHWESE.J ;
SMITH, TW .
NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (13) :651-654
[7]  
HILLESTA.L, 1974, CLIN PHARMACOL THER, V16, P479
[8]  
JALLING B, 1974, DEV MED CHILD NEUROL, V16, P781
[9]   PLASMA-LEVELS OF LIDOCAINE DURING COMBINED TREATMENT WITH PHENYTOIN AND PROCAINAMIDE [J].
KARLSSON, E ;
COLLSTE, P ;
RAWLINS, MD .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 7 (06) :455-459
[10]  
LOUS P, 1954, ACTA PHARMACOL TOX, V10, P147